Andreasen PA - Search Results

1

The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.

Offersen BV, Nielsen BS, Høyer-Hansen G, Rank F, Hamilton-Dutoit S, Overgaard J, Andreasen PA. Offersen BV, et al. Among authors: andreasen pa. Am J Pathol. 2003 Nov;163(5):1887-99. doi: 10.1016/S0002-9440(10)63547-X. Am J Pathol. 2003. PMID: 14578188 Free PMC article.

2

Vitronectin in human breast carcinomas.

Aaboe M, Offersen BV, Christensen A, Andreasen PA. Aaboe M, et al. Among authors: andreasen pa. Biochim Biophys Acta. 2003 May 20;1638(1):72-82. doi: 10.1016/s0925-4439(03)00059-0. Biochim Biophys Acta. 2003. PMID: 12757937 Free article.

3

Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1.

Illemann M, Hansen U, Nielsen HJ, Andreasen PA, Høyer-Hansen G, Lund LR, Danø K, Nielsen BS. Illemann M, et al. Among authors: andreasen pa. Am J Clin Pathol. 2004 Aug;122(2):256-65. doi: 10.1309/F32X-WQ20-T568-H8VP. Am J Clin Pathol. 2004. PMID: 15323143

4

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.

Offersen BV, Pfeiffer P, Andreasen P, Overgaard J. Offersen BV, et al. Lung Cancer. 2007 Apr;56(1):43-50. doi: 10.1016/j.lungcan.2006.11.018. Epub 2007 Jan 17. Lung Cancer. 2007. PMID: 17207889

5

Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa.

Gao S, Nielsen BS, Krogdahl A, Sørensen JA, Tagesen J, Dabelsteen S, Dabelsteen E, Andreasen PA. Gao S, et al. Among authors: andreasen pa. Genes Chromosomes Cancer. 2010 Jun;49(6):526-38. doi: 10.1002/gcc.20762. Genes Chromosomes Cancer. 2010. PMID: 20222049

6

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients.

Hansen S, Overgaard J, Rose C, Knoop A, Laenkholm AV, Andersen J, Sørensen FB, Andreasen PA. Hansen S, et al. Among authors: andreasen pa. Br J Cancer. 2003 Jan 13;88(1):102-8. doi: 10.1038/sj.bjc.6600662. Br J Cancer. 2003. PMID: 12556967 Free PMC article.

7

Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue.

Usher PA, Thomsen OF, Iversen P, Johnsen M, Brünner N, Høyer-Hansen G, Andreasen P, Danø K, Nielsen BS. Usher PA, et al. Among authors: andreasen p. Int J Cancer. 2005 Mar 1;113(6):870-80. doi: 10.1002/ijc.20665. Int J Cancer. 2005. PMID: 15515049 Free article.

8

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

Knoop A, Andreasen PA, Andersen JA, Hansen S, Laenkholm AV, Simonsen AC, Andersen J, Overgaard J, Rose C. Knoop A, et al. Among authors: andreasen pa. Br J Cancer. 1998 Mar;77(6):932-40. doi: 10.1038/bjc.1998.154. Br J Cancer. 1998. PMID: 9528837 Free PMC article.

9

Interconversion of active and inactive conformations of urokinase-type plasminogen activator.

Liu Z, Kromann-Hansen T, Lund IK, Hosseini M, Jensen KJ, Høyer-Hansen G, Andreasen PA, Sørensen HP. Liu Z, et al. Among authors: andreasen pa. Biochemistry. 2012 Oct 2;51(39):7804-11. doi: 10.1021/bi3005957. Epub 2012 Sep 19. Biochemistry. 2012. PMID: 22950516

10

Allosteric inactivation of a trypsin-like serine protease by an antibody binding to the 37- and 70-loops.

Kromann-Hansen T, Lund IK, Liu Z, Andreasen PA, Høyer-Hansen G, Sørensen HP. Kromann-Hansen T, et al. Among authors: andreasen pa. Biochemistry. 2013 Oct 8;52(40):7114-26. doi: 10.1021/bi400491k. Epub 2013 Sep 30. Biochemistry. 2013. PMID: 24079451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page